ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 135077 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 135077; 2) Community: the network communities that were significantly associated with the response to NSC 135077; 3) Molecule: the relationships between components within communities and NSC 135077; 4) MDR: the compounds that were significantly associated with the NSC 135077.

NSC Compound Enrichment Correlation
NSC 684409 18-Norestr-4-en-3-one, 17-ethynyl-13-ethyl- 17.beta.-hydroxy-,2-[(9,10-dihydro-10-oxo-4-acridinyl)carbonyl]hydrazone 0.0329129886465387 0.3586023
NSC 685285 Null 0.0329129886465387 0.13356435
NSC 685964 Null 0.0329129886465387 0.37390422
NSC 686551 Null 0.0329129886465387 0.26478046
NSC 688228 Null 0.0329129886465387 0.16542263
NSC 700862 4H-Cyclopenta[c]thiophen-4-one, 1,3-dichloro- 5,6-dihydro-6-hydroxy- 0.0329129886465387 0.1522321
NSC 715407 Null 0.0329129886465387 0.22261035
NSC 718781 Erlotinib hydrochloride 0.0329129886465387 0.116831
NSC 720134 Null 0.0329129886465387 -0.1723151
NSC 727620 6-[3-(2-Aminoethylamino)]-bis{1-propyl)-5,6-dihydro-2,3-dime thoxy-8,9-methylenedioxy-5,11-dioxo-11H-indeno[1,2-c]isoquin oline} dihydrochloride 0.0329129886465387 0.30079508
Total:126  Current:96    [First] [Prev] [Next] [Last]